Protalix BioTherapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Protalix BioTherapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $3.99M.
  • Protalix BioTherapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$8.91M, a 166% decline year-over-year.
  • Protalix BioTherapeutics, Inc. annual Operating Income (Loss) for 2023 was $10.5M.
  • Protalix BioTherapeutics, Inc. annual Operating Income (Loss) for 2022 was -$13M, a 36.4% increase from 2021.
  • Protalix BioTherapeutics, Inc. annual Operating Income (Loss) for 2021 was -$20.5M, a 855% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$8.91M $3.99M +$5.88M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$14.8M -$2.43M -$22.8M -112% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $8.06M -$4.86M -$2.4M -97.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $10.5M -$5.62M -$3.12M -125% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $13.6M -$1.89M +$1.24M +39.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $12.3M $20.4M +$25.9M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$13.6M -$2.46M -$589K -31.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$13M -$2.5M +$3.21M +56.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$16.2M -$3.13M -$1.24M -65.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$15M -$5.52M +$3.64M +39.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$18.6M -$1.87M +$1.84M +49.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$20.5M -$5.71M -$8.55M -301% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 -$11.9M -$1.89M +$697K +27% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$12.6M -$9.17M -$6.93M -309% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$5.69M -$3.71M -$8.4M -179% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $2.71M $2.84M +$639K +29% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $2.07M -$2.58M -$1.04M -67.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $3.11M -$2.24M +$3.6M +61.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$490K $4.69M +$10.2M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$10.7M $2.2M +$5.87M Oct 1, 2019 Dec 31, 2019 10-K 2020-03-12
Q3 2019 -$16.6M -$1.54M +$2.2M +58.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 -$18.8M -$5.84M +$905K +13.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$19.7M -$5.53M -$383K -7.44% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-01
Q4 2018 -$19.3M -$3.67M +$5.91M +61.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$25.2M -$3.74M +$4.02M +51.8% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 -$29.2M -$6.74M +$4.06M +37.6% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 -$33.3M -$5.15M +$1.21M +19.1% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
Q4 2017 -$34.5M -$9.58M -$862K -9.89% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 -$33.7M -$7.77M -$1.12M -16.8% Jul 1, 2017 Sep 30, 2017 10-Q/A 2019-03-18
Q2 2017 -$32.5M -$10.8M -$874K -8.8% Apr 1, 2017 Jun 30, 2017 10-Q/A 2019-03-18
Q1 2017 -$31.7M -$6.37M +$1.5M +19.1% Jan 1, 2017 Mar 31, 2017 10-Q/A 2019-03-18
Q4 2016 -$33.2M -$8.72M -$1.02M -13.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 -$32.1M -$6.65M -$1.65M -32.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$30.5M -$9.93M -$4.35M -77.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$26.2M -$7.86M -$2.48M -46.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$23.7M -$7.7M +$2.74M +26.2% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-06
Q3 2015 -$26.4M -$5M +$1.21M +19.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$27.6M -$5.58M -$137K -2.52% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$27.5M -$5.38M +$1.08M +16.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$28.6M -$10.4M +$6.66M +39% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$35.2M -$6.21M -$563K -9.97% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$34.7M -$5.45M +$1.45M +21% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$36.1M -$6.47M -$2.04M -46% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$34.1M -$17.1M -$6.93M -68.1% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-08
Q3 2013 -$27.1M -$5.65M -$85K -1.53% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$27.1M -$6.89M -$16.5M -172% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$10.5M -$4.43M +$1.64M +27% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 -$12.2M -$10.2M -$1.31M -14.8% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 -$10.9M -$5.56M +$3.21M +36.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 -$14.1M $9.62M +$23.5M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 -$37.6M -$6.07M -$1.03M -20.4% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$36.5M -$8.86M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-13
Q3 2011 -$8.77M -$5.92M -208% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 -$13.9M -$3.72M -36.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
Q1 2011 -$5.04M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 -$2.85M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 -$10.2M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.